Loading...
KIP logo

Kolinpharma S.p.A.BIT:KIP Stock Report

Market Cap €15.9m
Share Price
n/a
1Y22.8%
7D0%
1D0%
Portfolio Value
​
View

Kolinpharma S.p.A.

BIT:KIP Stock Report

Market Cap: €15.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kolinpharma (KIP) Stock Overview

Kolinpharma S.p.A. operates as a nutraceuticals company in Italy. More details

KIP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 8.06% per year

Risk Analysis

Does not have a meaningful market cap (€16M)

Profit margins (2.2%) are lower than last year (5%)


KIP Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW491,774 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
491,774 investors already sharing narratives
View all narratives

Kolinpharma S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kolinpharma
Historical stock prices
Current Share Price€9.90
52 Week High€10.00
52 Week Low€6.98
Beta0.65
1 Month Change0%
3 Month Change-0.50%
1 Year Change22.83%
3 Year Change22.22%
5 Year Change56.47%
Change since IPO41.65%

Recent News & Updates

Analysis Article • Jun 17

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Dec 01

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Kolinpharma S.p.A. ( BIT:KIP ), is not the largest company out there, but it saw significant share price movement...

Recent updates

Analysis Article • Jun 17

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Dec 01

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Kolinpharma S.p.A. ( BIT:KIP ), is not the largest company out there, but it saw significant share price movement...
Analysis Article • Aug 25

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Does the August share price for Kolinpharma S.p.A. ( BIT:KIP ) reflect what it's really worth? Today, we will estimate...
Analysis Article • Jun 08

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • May 21

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • May 03

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Today we will run through one way of estimating the intrinsic value of Kolinpharma S.p.A. ( BIT:KIP ) by taking the...
Analysis Article • Apr 13

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 22.3x Kolinpharma S.p.A. ( BIT:KIP ) may be sending bearish signals at the...
Analysis Article • Feb 20

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Kolinpharma S.p.A. ( BIT:KIP ), might not be a large cap stock, but it maintained its current share price over the past...
Analysis Article • Dec 28

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

It is hard to get excited after looking at Kolinpharma's (BIT:KIP) recent performance, when its stock has declined 7.1...
Analysis Article • Nov 22

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

KIPIT Personal ProductsIT Market
7D0%-0.3%-0.6%
1Y22.8%-3.9%25.3%

Return vs Industry: KIP exceeded the Italian Personal Products industry which returned 7.4% over the past year.

Return vs Market: KIP exceeded the Italian Market which returned 17.6% over the past year.

Price Volatility

Is KIP's price volatile compared to industry and market?
KIP volatility
KIP Average Weekly Movement1.1%
Personal Products Industry Average Movement5.0%
Market Average Movement4.6%
10% most volatile stocks in IT Market8.0%
10% least volatile stocks in IT Market3.0%

Stable Share Price: KIP has not had significant price volatility in the past 3 months.

Volatility Over Time: KIP's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013107Rita Petrelliwww.kolinpharma.com

Kolinpharma S.p.A. operates as a nutraceuticals company in Italy. The company engages in the development and marketing of food supplements. It provides multivitamins, energizers and dietetics, and drugs.

Kolinpharma S.p.A. Fundamentals Summary

How do Kolinpharma's earnings and revenue compare to its market cap?
KIP fundamental statistics
Market cap€15.91m
Earnings (TTM)€342.34k
Revenue (TTM)€15.62m
46.5x
P/E Ratio
1.0x
P/S Ratio

Is KIP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KIP income statement (TTM)
Revenue€15.62m
Cost of Revenue€7.39m
Gross Profit€8.23m
Other Expenses€7.89m
Earnings€342.34k

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.21
Gross Margin52.71%
Net Profit Margin2.19%
Debt/Equity Ratio105.3%

How did KIP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/01 14:04
End of Day Share Price 2023/09/27 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kolinpharma S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luigi TardellaEnVent Capital Markets Limited
Luisa PrimiIR Top Consulting S.r.l.